Related Experiment Video
Updated: May 8, 2026

13:47
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Overview: special focus vaccine acceptance
1Children's Hospital of Philadelphia; Philadelphia, PA USA.
Human Vaccines & Immunotherapeutics
|August 27, 2013
Summary
The "Decade of Vaccines" initiative aims to improve childhood vaccine access, potentially saving millions of lives. Addressing disparities in vaccine adoption and acceptance is crucial for global public health success.
Area of Science:
- Global Health
- Immunization Programs
- Public Health Policy
Background:
- The Gates Foundation's "Decade of Vaccines" initiative, launched in 2010 with a $10 billion commitment, aims to enhance access to existing and novel childhood vaccines.
- Vaccines represent a cornerstone of public health, historically reducing childhood disease prevalence, yet significant disparities in vaccine uptake persist globally.
- Declining vaccination rates in certain populations have led to resurgences of vaccine-preventable diseases, highlighting critical infrastructure and supply chain challenges.
Discussion:
- Persistent disparities in new vaccine adoption and sustained vaccination rates underscore the need for robust global health strategies.
- Factors contributing to these disparities include vaccine supply chain issues, inadequate infrastructure, and insufficient public health funding prioritization.
- Vaccine acceptance emerges as a critical, yet often overlooked, determinant of successful immunization program outcomes.
Key Insights:
- The
- Global health initiatives require multi-sectoral collaboration, involving health agencies, NGOs, industry, and governments, to ensure sustainable vaccine delivery.
- Addressing the multifaceted barriers to vaccine access and uptake is essential for realizing the full public health potential of immunization.
Outlook:
- Future efforts must focus on strengthening healthcare infrastructure and ensuring equitable vaccine distribution to overcome existing disparities.
- Enhancing vaccine acceptance through targeted public health communication and community engagement is vital for maintaining high vaccination rates and preventing disease outbreaks.
- Continued investment and collaborative action are necessary to achieve the ambitious goals set forth for global vaccine access and impact.
Related Concept Videos
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

